Literature DB >> 30569412

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.

Vasvi Singh1, Rodney Falk2, Marcelo F Di Carli1, Marie Kijewski1, Claudio Rapezzi3, Sharmila Dorbala4,5,6.   

Abstract

Cardiac amyloidosis, once considered untreatable, is now gaining well-deserved attention due to advances in imaging and the recent approval of targeted breakthrough therapies. In this paper, we discuss the role of radionuclide imaging in the evaluation and management of patients with the most common form of amyloidosis-cardiac transthyretin amyloidosis (ATTR). We provide a comprehensive summary of the literature interspersed with our institutional experience as appropriate, to deliver our perspective.

Entities:  

Keywords:  Amyloid heart disease; PET; SPECT; modalities; molecular imaging

Year:  2018        PMID： 30569412      PMCID： PMC6541031          DOI： 10.1007/s12350-018-01552-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  53 in total

Review 1.  AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.

Authors:  Rodney H Falk; Kevin M Alexander; Ronglih Liao; Sharmila Dorbala
Journal:  J Am Coll Cardiol       Date:  2016-09-20       Impact factor: 24.094

2.  Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study.

Authors:  W Phillip Law; William Wang; Peter Moore; Peter Mollee; Arnold Ng
Journal:  Amyloid       Date:  2017-03       Impact factor: 7.141

3.  Senile cardiac amyloidosis.

Authors:  A Pomerance
Journal:  Br Heart J       Date:  1965-09

4.  Scanning for soft-tissue amyloid.

Authors:  R W Kula; W K Engel; B R Line
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321

Review 5.  Metal complexes designed to bind to amyloid-β for the diagnosis and treatment of Alzheimer's disease.

Authors:  David J Hayne; SinChun Lim; Paul S Donnelly
Journal:  Chem Soc Rev       Date:  2014-03-27       Impact factor: 54.564

6.  The amyloidogenic V122I transthyretin variant in elderly black Americans.

Authors:  C Cristina Quarta; Joel N Buxbaum; Amil M Shah; Rodney H Falk; Brian Claggett; Dalane W Kitzman; Thomas H Mosley; Kenneth R Butler; Eric Boerwinkle; Scott D Solomon
Journal:  N Engl J Med       Date:  2015-01-01       Impact factor: 91.245

7.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Authors:  Enrica Perugini; Pier Luigi Guidalotti; Fabrizio Salvi; Robin M T Cooke; Cinzia Pettinato; Letizia Riva; Ornella Leone; Mohsen Farsad; Paolo Ciliberti; Letizia Bacchi-Reggiani; Francesco Fallani; Angelo Branzi; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

8.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

9.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

10.  Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.

Authors:  Isabelle Lousada; Raymond L Comenzo; Heather Landau; Spencer Guthrie; Giampaolo Merlini
Journal:  Adv Ther       Date:  2015-10-23       Impact factor: 3.845
View more
  19 in total

1.  Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis.

Authors:  Gary R Small; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2019-04-11       Impact factor: 5.952

2.  CPC Commentary on "Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management".

Authors:  Lawrence Phillips
Journal:  J Nucl Cardiol       Date:  2019-04-15       Impact factor: 5.952

3.  Semi-quantitative assessment of ischemia with rubidium-82 PET myocardial perfusion imaging.

Authors:  N M Borren; T J Gerritse; J P Ottervanger; M Mouden; J R Timmer; J A van Dalen; P L Jager; J D van Dijk
Journal:  J Nucl Cardiol       Date:  2021-12-30       Impact factor: 5.952

4.  Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.

Authors:  Marcus V Simões; Fabio Fernandes; Fabiana G Marcondes-Braga; Philip Scheinberg; Edileide de Barros Correia; Luis Eduardo P Rohde; Fernando Bacal; Silvia Marinho Martins Alves; Sandrigo Mangini; Andréia Biolo; Luis Beck-da-Silva; Roberta Shcolnik Szor; Wilson Marques Junior; Acary Souza Bulle Oliveira; Márcia Waddington Cruz; Bruno Vaz Kerges Bueno; Ludhmila Abrahão Hajjar; Aurora Felice Castro Issa; Felix José Alvarez Ramires; Otavio Rizzi Coelho Filho; André Schmidt; Ibraim Masciarelli Francisco Pinto; Carlos Eduardo Rochitte; Marcelo Luiz Campos Vieira; Cláudio Tinoco Mesquita; Celso Dario Ramos; José Soares-Junior; Minna Moreira Dias Romano; Wilson Mathias Junior; Marcelo Iório Garcia Junior; Marcelo Westerlund Montera; Marcelo Dantas Tavares de Melo; Sandra Marques E Silva; Pedro Manoel Marques Garibaldi; Aristóteles Comte de Alencar Neto; Renato Delascio Lopes; Diane Xavier de Ávila; Denizar Viana; José Francisco Kerr Saraiva; Manoel Fernandes Canesin; Glaucia Maria Moraes de Oliveira; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

Review 5.  Multimodality cardiac imaging in the 21st century: evolution, advances and future opportunities for innovation.

Authors:  Melissa A Daubert; Tina Tailor; Olga James; Leslee J Shaw; Pamela S Douglas; Lynne Koweek
Journal:  Br J Radiol       Date:  2020-11-25       Impact factor: 3.039

6.  Initial experience regarding the safety and yield of rest-stress myocardial perfusion imaging in emergency department patients with mildly abnormal high-sensitivity cardiac troponins.

Authors:  Rakesh Engineer; Arooj Khan; Sihe Wang; Wael A Jaber; Venu Menon; Paul C Cremer
Journal:  J Nucl Cardiol       Date:  2020-06-17       Impact factor: 5.952

Review 7.  Nuclear Imaging for Cardiac Amyloidosis: Bone Scan, SPECT/CT, and Amyloid-Targeting PET.

Authors:  Jin Chul Paeng; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2021-01-07

Review 8.  Updates in Cardiac Amyloidosis Diagnosis and Treatment.

Authors:  Lily K Stern; Michelle M Kittleson
Journal:  Curr Oncol Rep       Date:  2021-03-16       Impact factor: 5.075

9.  Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis.

Authors:  Nina Makivic; Claudia Stöllberger; Thomas Nakuz; Birke Schneider; Christine Schmid; Matthias Hasun; Franz Weidinger
Journal:  ESC Heart Fail       Date:  2020-06-09

Review 10.  Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.

Authors:  Teodor M Ionescu; Wael Jalloul; Cati R Stolniceanu; Roxana Iacob; Laura P Grecu; Ana-Maria Stătescu; Irena Grierosu; Mihai Guțu; Adrian Gavrilescu; Crișu Daniela; Antoniu Petriș; Manuela Ciocoiu; Cristina Ungureanu; Cipriana Ștefănescu
Journal:  Ann Nucl Med       Date:  2021-07-17       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.